New Diagnostic Film Explains Clinical Testing Mechanics
The release aims to demystify laboratory analyzer protocols and antibody stripping methods for a general audience.
Updated on Oct. 30, 2026 in Biotech
Live Poll
Do you believe public scientific debates benefit when independent experts challenge mainstream investigative journalism?
Laboratory diagnostics veteran Ryan ElHosseiny released a new short film, Lab Stripping, to explain the mechanics behind clinical testing and data interpretation. The film explores technical processes like the Glycine Stripping Protocol and the internal logic of diagnostic hardware.
Why it matters
The release aims to demystify complex diagnostic terminology and machine operations for the public, grounding industry practices in verifiable laboratory science. It serves as a commentary on the transparency and accuracy of testing protocols currently used in clinical diagnostics.
The Bio-Rad BioPlex 2200 analyzer utilizes a strict two-out-of-three rule, requiring an HIV analyte to show at least two reactive results out of three attempts to be deemed repeatedly reactive.
The players
Ryan ElHosseiny
A veteran of laboratory diagnostics with 20 years of professional experience.
John Carreyrou
An investigative journalist and author of Bad Blood who covers corporate fraud and laboratory testing.
Bio-Rad Laboratories
A life sciences company that produces automated diagnostic testing hardware like the BioPlex 2200.
The details
The Glycine Stripping Protocol is a specialized technique designed to remove bound antibodies from a testing target, allowing for cleaner downstream analysis. When a sample initially tests as reactive, the Bio-Rad protocol necessitates that the specimen be retested in duplicate to verify the initial finding. These automated laboratory analyzers act as the central control for executing these complex test sequences, including reagent mixing and sample preparation.
Timeline
April 22, 2025: ElHosseiny presented The Strip Club at LIV Nightclub.
October 30, 2026: Lab Stripping film release announced.
The Tech Race
This release follows the precedent of the Theranos investigation detailed in Bad Blood by calling for greater transparency in diagnostic machine validation. It marks a push by industry experts to clarify the operational reality of testing hardware versus public perception.
This film provides context for anyone seeking to understand how clinical labs verify high-stakes medical results. Viewers can access additional explanations and data through the resources provided on the creator's platform.
The takeaway
The industry continues to grapple with the gap between proprietary diagnostic software logic and external auditability. Watch for continued technical discourse surrounding whether two-out-of-three verification rules meet modern clinical standards.
Further reading
For more on the current landscape of laboratory standards, see our Biotech section.
More information
For more on the science behind these diagnostic processes, visit ElHosseiny's website.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you believe public scientific debates benefit when independent experts challenge mainstream investigative journalism?
